Authors
Loading...
Molecular docking demonstrates strong antimicrobial potential in benzimidazo-quinazoline derivatives against Staphylococcus aureus, suggesting new antibiotic development.
R et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: